目的 評價云南白藥膠囊在減少經尿道前列腺電切術(TURP)術中出血的療效與安全性.方法 采用隨機、雙盲、對照的試驗方法,將40例接受TURP手術的患者隨機分為試驗組和安慰劑組.試驗組(n=20)術前3天起口服云南白藥膠囊,每次0.25 g/粒,2粒,一日4次.對照組(n=20)術前3天起口服空白淀粉膠囊.術中監測沖洗液的出血總量、腺體出血指數、出血強度,比較兩組住院時間、尿管保留時間及術后膀胱沖洗的時間.結果 試驗組在TURP出血總量、腺體出血指數及出血強度明顯低于對照組,其差異有統計學意義(Plt;0.05);但平均住院時間、術后保留尿管時間和術后膀胱沖洗時間與對照組比較,其差異均無統計學意義(Pgt;0.05).用藥期間,兩組均無明顯毒副反應發生.結論 云南白藥膠囊能減少TURP術中出血量,且無明顯副作用,是一種安全有效的術后止血方法.
摘要:目的:探討良性前列腺增生經尿道前列腺電切術圍手術期的護理經驗。方法:回顧性分析96例良性前列腺增生患者臨床資料。結果:96例患者手術順利,圍手術期經周密的護理,療效滿意,無明顯并發癥。結論:周密的手術期護理對經尿道前列腺電切術治療老年良性前列腺增生十分重要。Abstract: Objective: To investigate the perioperative nursing care of transurethral prostatic resection (TURP). Methods: The data of 96 TURP cases were analyzed retrospectively. Results: All the operations were performed successfully, and there were no obvious complications among the patients with precise nursing care. Conclusion: It is very important for precise nursing care to the patients who underwent TURP.
摘要:目的:探討經尿道前列腺電切術中糖尿病患者血糖變化以及處理對策。方法:2006年7月~ 2009年1月共對80例患有前列腺增生合并糖尿病患者行TURP,同期對80例單純性前列腺增生患者進行相同手術,回顧分析其術前、術中30 min、60 min、90 min 指尖血糖變化及干預情況。結果:治療組80例患者,51例術中血糖值明顯低于術前,分別為1.8～3 mmol/L;對照組術前與術中血糖值基本一致,血糖波動于4.5～5.6 mmol/L。結論:糖尿病患者糖的儲備能力差,在行經尿道電切術中易發生低血糖綜合征,術中及時的血糖監測及干預對保證患者的安全有重要意義。Abstract: Objective: To study the changes and measures against the glucose in the operation of the Diabetes by TURP. Methods:Eighty patients with prostate combining diabetes operated from July 2006 to Jan. 2009 were reviewed, and 80 prostate treated at the same period with the same operation measure were selected as control. The preoperative glucose, intraoperative glucose (30′, 60′,90′) of fingertip, and countermeasures were studied and compared between the two groups. Results:Fiftyone cases of the experimental group of intraoperative blood glucose was significantly lower than preoperative values, respectively 1.83 mmol/ L; control group preoperative and intraoperative blood glucose values were basically the same, blood glucose fluctuations in the 4.55.6 mmol/L. Conclusion: The capacity in patients with diabetes is poor, easy to hypoglycemia syndrome in the act of TURP surgery, intraoperative blood glucose monitoring and timely intervention to ensure patient safety significance.